Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-04-15

Clinical Trial Update: Monitoring of the End-tidal Carbon Dioxide (EtCO2) as a Severity Criterion in COPD Exacerbations

View source ↗

Summary

This clinical trial is evaluating whether monitoring end-tidal CO2 can help gauge severity in COPD exacerbations and is currently recruiting at University Hospi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University Hospital, Grenoble | Conditions: Pulmonary Disease, Chronic Obstructive, Exacerbation Copd | Status: RECRUITING